(Executive) Director & Head of US Pharmacometrics

  • Led a global group of quantitative clinical pharmacologists that accelerate and streamline drug development by applying model-informed drug development approaches in the therapeutic areas respiratory, immunology, central nervous system, cardiovascular and metabolism. Senior group members lead early clinical development teams and are responsible for delivering overall drug development strategies including biomarker and clinical pharmacology strategies to senior management committees. 
  • Co-led a project how microsegmentation and microtargeting could be leveraged in direct-to-consumer marketing that was sponsored by Human Pharma Leadership Team
  • Led development and implementation of global pharmacometrics strategy